Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | +10.53% |
|
+13.51% | +20.00% |
06-20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
06-12 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
- Stock Market
- Equities
- TLT Stock
- Revisions Theralase Technologies Inc.